Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
about
Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: Report of the Guideline Development Subcommittee of the American Academy of NeurologyBenefits and harms of endoscopic screening for gastric cancerSafe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksProthrombotic and hemorrhagic effects of aspirin.Perioperative Management of Neurological Conditions.Low risk of rebound events after a short course of clopidogrel in acute TIA or minor stroke.Thrombotic events associated to aspirin therapy.Evaluation of postextraction bleeding incidence to compare patients receiving and not receiving warfarin therapy: a cross-sectional, multicentre, observational study.Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agentsThe postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissectionDiscontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary careRisk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes.Withdrawal of antithrombotic agents and its impact on ischemic stroke occurrence.Spontaneous Early Recanalization after Acute Innominate Artery Thromboembolic Occlusion Secondary to Abrupt Aspirin and Statin Discontinuation: A Case Report.Interruption to antiplatelet therapy early after acute ischaemic stroke: a nested case-control study.Use of a haemostatic matrix (Floseal®) does not reduce blood loss in minimally invasive total knee arthroplasty performed under continued aspirin.Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelinesWithdrawal of Antithrombotic Agents and the Risk of Stroke.The preoperative neurological evaluation.Discontinuation of low-dose acetylsalicylic acid therapy in UK primary care: incidence and predictors in patients with cardiovascular disease.Risk factors for the effect of anticoagulant and antiplatelet agents on perioperative blood loss following proximal femoral fractures.Effects of Aspirin Therapy on Ultrasound-Guided Renal Allograft Biopsy Bleeding ComplicationsAspirin allergy desensitization in cerebrovascular disease. A report of two cases, literature review and management guide for the neurointerventionalist.Gastrointestinal effects of aspirin.Commonly asked questions in the management of perioperative stroke.Special care dentistry for general dental practice.Aspirin for cardioprotection and strategies to improve patient adherence.Management of antithrombotic therapy in patients undergoing electrophysiological device surgery.Continued administration of antithrombotic agents during transperineal prostate biopsyPercutaneous native kidney biopsy in patients receiving antiplatelet agents- is it necessary to stop them routinely?Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts.Endoscopy in Patients on Antiplatelet Agents and Anticoagulants.Multicenter Prospective Study on the Safety of Upper Gastrointestinal Endoscopic Procedures in Antithrombotic Drug Users.Quality assurance manual of endoscopic screening for gastric cancer in Japanese communities.Safety of dual antiplatelet therapy in daily cardiology practice.Evaluation of the bleeding risk with various antithrombotic therapies after gastric endoscopic submucosal dissection.Transperineal ultrasound-guided prostate biopsy is safe even when patients are on combination antiplatelet and/or anticoagulation therapy.Postoperative bleeding in patients on antithrombotic therapy after gastric endoscopic submucosal dissection.Risk of bleeding after endoscopic submucosal dissection for colorectal tumors in patients with continued use of low-dose aspirin.Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy.
P2860
Q22306177-46AB2618-7680-4BA8-BB22-0E119932FDE4Q28079409-79999A46-14E5-42E0-8AE6-FBE00AC26518Q30629677-17F23CF9-D725-468D-8B68-0DB0046C7683Q33349385-71C15B0C-CAB6-48CF-9EE4-AE78887D9899Q33797928-741824EB-378E-4F88-9D60-6C58109FB612Q33899911-5C4CA0DA-4F0A-4214-AA08-E724914261ECQ34111104-E64FAA3E-5CB6-4A3D-87D5-45418ADB1E63Q34707532-BA918C02-3C02-46B6-857D-6BF871D0ACD1Q34873381-B222260E-1340-4B41-8A52-0BC0850C890CQ34980127-2AD4A61C-6046-4B38-8B2A-3A81A8230942Q35116433-211A6563-2636-46AF-B73E-781C662A2E9DQ35117393-2F5A8275-A0DD-4116-8C3F-F7D351D873E3Q35194074-55557E1E-A163-4EA2-A0E3-41042F5A0C3AQ36306521-0CE11D03-A872-4E1E-8072-3C5651953A7CQ36310002-DDBEF791-7E99-4467-845A-E071D85095B8Q36660762-38A084F1-5AC2-4A8E-89EF-AAAAC29B8E91Q36682317-F3C6CE4E-C6EF-4C20-AA1A-ACCE41758B2AQ36706241-B787E013-021E-4D28-B2DB-9227398FDE78Q37262132-7563F967-E979-40F0-A7D6-E9C05D631F24Q37300872-85FAD5A5-B15E-4CB3-B789-B0FDECADF8D1Q37328107-EBA7DB46-D018-4255-835F-62125464E424Q37601329-BF19A5D6-544B-4B7A-864A-DF6094C3D6A5Q37676410-806A9B4F-D71B-43E7-93B4-DBD2EF9BCE55Q37885723-DFA8D403-3428-42EC-A245-0C07676D217EQ38078027-86291387-819F-458A-8278-244AFC252843Q38130974-3B588B16-965D-4EE1-8FE7-8FB54F63EFBFQ38176141-127A7290-8BD0-41B9-9422-F12DE3A04F26Q38364982-2752966B-D4A6-40BB-8E5B-7D398BB85911Q38391567-C3F56AF9-2122-4B00-8DD4-72DD5C6C5DB6Q38523257-93126A2E-A4F6-4542-AF6F-B2BEE7112C00Q38906252-B57AFD7D-F68F-4A15-A1E3-5907E64C35F6Q39328083-4CDDDAA0-46C5-47A6-AA16-A2AB2EBD1365Q40386316-AC9F7D21-B63C-4882-87BF-30ED32140AAEQ40553543-66518B95-0588-4790-B85B-11E34ECBD376Q40610419-98723B50-2D53-4E13-8D80-7ED40266263BQ40952316-BB86B7F2-4E29-416D-9526-D37692BA5A54Q40954409-2BE0E697-D347-451C-BEBB-B04A7B9955F5Q41426404-7DC2BD10-A116-406D-BED1-4591D5F30992Q41435727-DD136AC3-CFED-4F6E-96AE-600A1BC40E13Q41997560-A2E2A722-FADB-4864-B285-C313F7932A51
P2860
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
@ast
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
@en
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
@nl
type
label
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
@ast
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
@en
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
@nl
prefLabel
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
@ast
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
@en
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
@nl
P2093
P3181
P1433
P1476
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
@en
P2093
Alexandre Balzano Maulaz
Daniel C Bezerra
Julien Bogousslavsky
Patrik Michel
P304
P3181
P356
10.1001/ARCHNEUR.62.8.1217
P407
P577
2005-08-01T00:00:00Z